Article Details

Qu Biologics to Launch Phase 2B Clinical Trial to Assess Reduction of Postoperative ... - BioSpace

Retrieved on: 2022-09-26 19:24:24

Tags for this article:

Click the tags to see associated articles and topics

Qu Biologics to Launch Phase 2B Clinical Trial to Assess Reduction of Postoperative ... - BioSpace. View article details on HISWAI: https://www.biospace.com/article/releases/qu-biologics-to-launch-phase-2b-clinical-trial-to-assess-reduction-of-postoperative-immune-suppression-and-disease-progression-in-patients-with-late-stage-colorectal-cancer/

Excerpt

By programming immune cells to remain functionally active to deal with any postoperative remnants of cancer and targeting that response to the ...

Article found on: www.biospace.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up